• Skip to primary navigation
  • Skip to main content
AR Prevention

AR Prevention

AR Prevention

  • About Us
    • SEOW Core Members
    • Arkansas Statewide Epidemiological Outcomes Workgroup Charter
    • Logic Model
    • Contact Us!
  • Reports
  • Tools
  • Media
  • Meeting Archives
  • Resources
    • Data Indicators
    • Prescription Drug Use Trends
  • Blog

Data Indicators

Arkansas Population Profile:   Population, Age, Race/Ethnicity

Household type, marital status, fertility, educational attainment/enrollment, veteran status, disability status, computer & internet use  

Employment status, occupation, income, health insurance, poverty status
US Census Bureau, American Community Survey
Census – Table Results    
Census – Table Results                  





Census – Table Results
Arkansas UnemploymentDepartment of Labor, Bureau of Labor Statistics Bureau of Labor Statistics Data (bls.gov)
Arkansas Uninsured – state and countyUS Census Bureau, American Community Survey Census – Table Results
Arkansas Rural PopulationUS Department of Agriculture, ERS USDA ERS – Rural-Urban Continuum Codes
Self Rated Health StatusBehavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC
Adult HypertensionBehavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC
Adult High CholesterolBehavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC
Adult ArthritisBehavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC
Youth Electronic Vapor Product UseArkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com)
Youth Age of first cigarette useYouth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC
Cigarettes and smokeless tobacco lifetime useArkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com)
Cigarettes and smokeless tobacco current useArkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com)
Electronic vapor product lifetime useYouth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC
Lifetime alcohol useArkansas Prevention Needs Assessment/Youth Risk Behavioral Surveillance Survey (YRBSS)** Arkansas Prevention Needs Assessment Survey (pridesurveys.com)Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC
Average age of first alcohol useArkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com)
Current alcohol useArkansas Prevention Needs Assessment/Youth Risk Behavioral Surveillance Survey (YRBSS)** Arkansas Prevention Needs Assessment Survey (pridesurveys.com)Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC
Current binge drinkingArkansas Prevention Needs Assessment/Youth Risk Behavioral Surveillance Survey (YRBSS)** Arkansas Prevention Needs Assessment Survey (pridesurveys.com)Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC
Current marijuana useArkansas Prevention Needs Assessment/Youth Risk Behavioral Surveillance Survey (YRBSS)** Arkansas Prevention Needs Assessment Survey (pridesurveys.com)Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC
Lifetime marijuana useArkansas Prevention Needs Assessment/Youth Risk Behavioral Surveillance Survey (YRBSS)** Arkansas Prevention Needs Assessment Survey (pridesurveys.com)Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC
Average age of first marijuana useArkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com)
Lifetime prescription drug misuseYouth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC
Current prescription drug misuseArkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com)
Age of first misuse of prescription drugsArkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com)
Youth current drug abuseArkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com)
Youth lifetime drug abuseArkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com)
Youth lifetime illegal drug injectedYouth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC
Adult current smokersBehavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC
Smoking 3 months prior to pregnancyPregnancy Risk Assessment Monitoring System Prevalence of Selected Maternal and Child Health Indicators for Arkansas, Pregnancy Risk Assessment Monitoring System (PRAMS), 2016-2019 (cdc.gov)
Smoking last 3 months of pregnancyPregnancy Risk Assessment Monitoring System Prevalence of Selected Maternal and Child Health Indicators for Arkansas, Pregnancy Risk Assessment Monitoring System (PRAMS), 2016-2019 (cdc.gov)
Smoking after deliveryPregnancy Risk Assessment Monitoring System Prevalence of Selected Maternal and Child Health Indicators for Arkansas, Pregnancy Risk Assessment Monitoring System (PRAMS), 2016-2019 (cdc.gov)
Alcohol Use 3 months before pregnancyPregnancy Risk Assessment Monitoring System Prevalence of Selected Maternal and Child Health Indicators for Arkansas, Pregnancy Risk Assessment Monitoring System (PRAMS), 2016-2019 (cdc.gov)
Adult current alcohol useBehavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC
Adult Binge drinkingBehavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC
Adult heavy drinkingBehavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC
Adult current marijuana useNational Survey on Drug Use and Health SAMHDA (samhsa.gov)
Adult past year marijuana useNational Survey on Drug Use and Health SAMHDA (samhsa.gov)
Drug related arrests for marijuana/hashishArkansas Crime Information Center (ACIC) Crime Statistics – Arkansas Department of Public Safety
Drug overdose deaths in the USCenters for Disease Control 2019 Drug Overdose Death Rates | Drug Overdose | CDC Injury Center
Opioid related overdose deaths per 100,000Centers for Disease Control 2018-2019 Prescription Opioid Overdose Data | Drug Overdose | CDC Injury Center
Opioid prescriptions per 100 persons by countyCenters for Disease Control U.S. County Opioid Dispensing Rates, 2020 | Drug Overdose | CDC Injury Center
Adult cocaine useNational Survey on Drug Use and Health SAMHDA (samhsa.gov)
Adult methamphetamine useNational Survey on Drug Use and Health SAMHDA (samhsa.gov)
Adult illicit drug use in the past 3 monthsNational Survey on Drug Use and Health SAMHDA (samhsa.gov)
Tobacco use during pregnancyPregnancy Risk Assessment Monitoring System Prevalence of Selected Maternal and Child Health Indicators for Arkansas, Pregnancy Risk Assessment Monitoring System (PRAMS), 2016-2019 (cdc.gov)
Rate of neonatal abstinence syndromeArkansas Department of Health, Prescription Monitoring Program Prescription Drug Monitoring Program Arkansas Department of Health
Percentage with angina or coronary heart diseaseBehavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC
Percentage with strokeBehavioral Risk Factor Surveillance Survey (BRFSS) Behavioral Risk Factor Surveillance System | DPH | CDC
Percentage with heart attackBehavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC
Percentage with COPDBehavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC
Age adjusted mortality rate for smoking related cancers, respiratory and cardiovascular diseases*Centers for Disease Control, Multiple Cause of Death Multiple Cause of Death, 2018-2020, Single Race Results Form (cdc.gov)
Age adjusted mortality rate for alcoholic fatty liver disease, ICD10 K70Centers for Disease Control Multiple Cause of Death, 2018-2020, Single Race Results Form (cdc.gov)
Academic PerformanceArkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com)
Suicide rates in ArkansasCenters for Disease Control, CDC Wonder Multiple Cause of Death, 2018-2020, Single Race Results Form (cdc.gov)
Rate of attempted suicideYouth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC
Rate of injurious suicideYouth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC
Drug and alcohol related arrests in ArkansasArkansas Crime Information Center (ACIC) Crime Statistics – Arkansas Department of Public Safety
Alcohol related crash fatalitiesUS Department of Transportation, Fatality Analysis Reporting System Fatality Analysis Reporting System (FARS) | NHTSA
Risk perception – smoking, marijuana, alcoholArkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com)
Youth feeling sad or hopelessYouth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC
Adult depressionBehavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC
Major depressive episode by ageNational Survey on Drug Use and Health SAMHDA (samhsa.gov)
Percentage of students protected by religiosityArkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com)
Poor mental health in adultsBehavioral Risk Factor Surveillance Survey (BRFSS) Behavioral Risk Factor Surveillance System | DPH | CDC”
Parents/Peers with attitudes favorable to drug useArkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com)
Students bullied at schoolYouth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC
Students bullied electronicallyYouth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC
Transitions and mobilityArkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com)
Rate of homelessness per 100 children enrolled in Arkansas public schoolsArkansas Department of Education Data Center Statewide Information System Reports (arkansas.gov)
Percentage Tobacco sales to minorsArkansas Tobacco Control Arkansas Tobacco Control Board
People in alcohol or drug treatmentArkansas Department of Human Services Statistical Reports – Arkansas Department of Human Services
People needing but not receiving treatmentNational Survey on Drug Use and Health SAMHDA (samhsa.gov)
Food insecurityBy state, U.S. Department of Agriculture, Economic Research Service foodsecurity_data_file.xlsx (live.com) By county, U.S. Department of Agriculture, Economic Research Service, Food Atlas USDA ERS – Data Access and Documentation Downloads
Retail Alcohol EstablishmentsU.S. Census Bureau, County Business Patterns County Business Patterns (CBP) Tables (census.gov)
Disconnected YouthAmerican Community Survey, Table B14005 Census – Table Results
Overcrowded HousingAmerican Community Survey, Table DP04 Census – Table Results
GINI measure of income inequalityAmerican Community Survey Census – Table Results

*    Smoking related cancers include lip, oral cavity, and pharynx; esophagus; stomach; pancreas; larynx; trachea, bronchus, and lung; cervix; bladder; kidney and other urinary tract; and acute myeloid leukemia.  Cardiovascular diseases related to smoking include coronary heart disease; other heart disease; cerebrovascular disease; atherosclerosis; aortic aneurysm; and other arterial disease.  Smoking related respiratory diseases include pneumonia and influenza; bronchitis and emphysema; and COPD.  ICD10 codes include C00.0 (External upper lip – Malignant neoplasms); C00.1 (External lower lip – Malignant neoplasms); C00.2 (External lip, unspecified – Malignant neoplasms); C00.3 (Upper lip, inner aspect – Malignant neoplasms); C00.4 (Lower lip, inner aspect – Malignant neoplasms); C00.5 (Lip, unspecified, inner aspect – Malignant neoplasms); C00.6 (Commissure of lip – Malignant neoplasms); C00.8 (Overlapping lesion of lip – Malignant neoplasms); C00.9 (Lip, unspecified – Malignant neoplasms); C01 (Malignant neoplasm of base of tongue); C02.0 (Dorsal surface of tongue – Malignant neoplasms); C02.1 (Border of tongue – Malignant neoplasms); C02.2 (Ventral surface of tongue – Malignant neoplasms); C02.3 (Anterior two-thirds of tongue, part unspecified – Malignant neoplasms); C02.4 (Lingual tonsil – Malignant neoplasms); C02.8 (Overlapping lesion of tongue – Malignant neoplasms); C02.9 (Tongue, unspecified – Malignant neoplasms); C03.0 (Upper gum – Malignant neoplasms); C03.1 (Lower gum – Malignant neoplasms); C03.9 (Gum, unspecified – Malignant neoplasms); C04.0 (Anterior floor of mouth – Malignant neoplasms); C04.1 (Lateral floor of mouth – Malignant neoplasms); C04.8 (Overlapping lesion of floor of mouth – Malignant neoplasms); C04.9 (Floor of mouth, unspecified – Malignant neoplasms); C05.0 (Hard palate – Malignant neoplasms); C05.1 (Soft palate – Malignant neoplasms); C05.2 (Uvula – Malignant neoplasms); C05.8 (Overlapping lesion of palate – Malignant neoplasms); C05.9 (Palate, unspecified – Malignant neoplasms); C06.0 (Cheek mucosa – Malignant neoplasms); C06.1 (Vestibule of mouth – Malignant neoplasms); C06.2 (Retromolar area – Malignant neoplasms); C06.8 (Overlapping lesion of other and unspecified parts of mouth – Malignant neoplasms); C06.9 (Mouth, unspecified – Malignant neoplasms); C07 (Malignant neoplasm of parotid gland); C08.0 (Submandibular gland – Malignant neoplasms); C08.1 (Sublingual gland – Malignant neoplasms); C08.8 (Overlapping lesion of major salivary glands – Malignant neoplasms); C08.9 (Major salivary gland, unspecified – Malignant neoplasms); C09.0 (Tonsillar fossa – Malignant neoplasms); C09.1 (Tonsillar pillar (anterior)(posterior) – Malignant neoplasms); C09.8 (Overlapping lesion of tonsil – Malignant neoplasms); C09.9 (Tonsil, unspecified – Malignant neoplasms); C10.0 (Vallecula – Malignant neoplasms); C10.1 (Anterior surface of epiglottis – Malignant neoplasms); C10.2 (Lateral wall of oropharynx – Malignant neoplasms); C10.3 (Posterior wall of oropharynx – Malignant neoplasms); C10.4 (Branchial cleft – Malignant neoplasms); C10.8 (Overlapping lesion of oropharynx – Malignant neoplasms); C10.9 (Oropharynx, unspecified – Malignant neoplasms); C11.0 (Superior wall of nasopharynx – Malignant neoplasms); C11.1 (Posterior wall of nasopharynx – Malignant neoplasms); C11.2 (Lateral wall of nasopharynx – Malignant neoplasms); C11.3 (Anterior wall of nasopharynx – Malignant neoplasms); C11.8 (Overlapping lesion of nasopharynx – Malignant neoplasms); C11.9 (Nasopharynx, unspecified – Malignant neoplasms); C12 (Malignant neoplasm of pyriform sinus); C13.0 (Postcricoid region – Malignant neoplasms); C13.1 (Aryepiglottic fold, hypopharyngeal aspect – Malignant neoplasms); C13.2 (Posterior wall of hypopharynx – Malignant neoplasms); C13.8 (Overlapping lesion of hypopharynx – Malignant neoplasms); C13.9 (Hypopharynx, unspecified – Malignant neoplasms); C14.0 (Pharynx, unspecified – Malignant neoplasms); C14.2 (Malignant neoplasm of Waldeyer ring); C14.8 (Overlapping lesion of lip, oral cavity and pharynx – Malignant neoplasms); C15.0 (Cervical part of oesophagus – Malignant neoplasms); C15.1 (Thoracic part of oesophagus – Malignant neoplasms); C15.2 (Abdominal part of oesophagus – Malignant neoplasms); C15.3 (Upper third of oesophagus – Malignant neoplasms); C15.4 (Middle third of oesophagus – Malignant neoplasms); C15.5 (Lower third of oesophagus – Malignant neoplasms); C15.8 (Overlapping lesion of oesophagus – Malignant neoplasms); C15.9 (Oesophagus, unspecified – Malignant neoplasms); C16.0 (Cardia – Malignant neoplasms); C16.1 (Fundus of stomach – Malignant neoplasms); C16.2 (Body of stomach – Malignant neoplasms); C16.3 (Pyloric antrum – Malignant neoplasms); C16.4 (Pylorus – Malignant neoplasms); C16.5 (Lesser curvature of stomach, unspecified – Malignant neoplasms); C16.6 (Greater curvature of stomach, unspecified – Malignant neoplasms); C16.8 (Overlapping lesion of stomach – Malignant neoplasms); C16.9 (Stomach, unspecified – Malignant neoplasms); C25.0 (Head of pancreas – Malignant neoplasms); C25.1 (Body of pancreas – Malignant neoplasms); C25.2 (Tail of pancreas – Malignant neoplasms); C25.3 (Pancreatic duct – Malignant neoplasms); C25.4 (Endocrine pancreas – Malignant neoplasms); C25.7 (Other parts of pancreas – Malignant neoplasms); C25.8 (Overlapping lesion of pancreas – Malignant neoplasms); C25.9 (Pancreas, unspecified – Malignant neoplasms); C32.0 (Glottis – Malignant neoplasms); C32.1 (Supraglottis – Malignant neoplasms); C32.2 (Subglottis – Malignant neoplasms); C32.3 (Laryngeal cartilage – Malignant neoplasms); C32.8 (Overlapping lesion of larynx – Malignant neoplasms); C32.9 (Larynx, unspecified – Malignant neoplasms); C33 (Malignant neoplasm of trachea); C34.0 (Main bronchus – Malignant neoplasms); C34.1 (Upper lobe, bronchus or lung – Malignant neoplasms); C34.2 (Middle lobe, bronchus or lung – Malignant neoplasms); C34.3 (Lower lobe, bronchus or lung – Malignant neoplasms); C34.8 (Overlapping lesion of bronchus and lung – Malignant neoplasms); C34.9 (Bronchus or lung, unspecified – Malignant neoplasms); C53.0 (Endocervix – Malignant neoplasms); C53.1 (Exocervix – Malignant neoplasms); C53.8 (Overlapping lesion of cervix uteri – Malignant neoplasms); C53.9 (Cervix uteri, unspecified – Malignant neoplasms); C64 (Malignant neoplasm of kidney, except renal pelvis); C67.0 (Trigone of bladder – Malignant neoplasms); C67.1 (Dome of bladder – Malignant neoplasms); C67.2 (Lateral wall of bladder – Malignant neoplasms); C67.3 (Anterior wall of bladder – Malignant neoplasms); C67.4 (Posterior wall of bladder – Malignant neoplasms); C67.5 (Bladder neck – Malignant neoplasms); C67.6 (Ureteric orifice – Malignant neoplasms); C67.7 (Urachus – Malignant neoplasms); C67.8 (Overlapping lesion of bladder – Malignant neoplasms); C67.9 (Bladder, unspecified – Malignant neoplasms); C68.0 (Urethra – Malignant neoplasms); C68.1 (Paraurethral gland – Malignant neoplasms); C68.8 (Overlapping lesion of urinary organs – Malignant neoplasms); C68.9 (Urinary organ, unspecified – Malignant neoplasms); C92.0 (Acute myeloid leukaemia – Malignant neoplasms); I25.1 (Atherosclerotic heart disease); I25.8 (Other forms of chronic ischaemic heart disease); I60-I69 (Cerebrovascular diseases); I70.0 (Atherosclerosis of aorta); I70.1 (Atherosclerosis of renal artery); I70.2 (Atherosclerosis of arteries of extremities); I70.8 (Atherosclerosis of other arteries); I70.9 (Generalized and unspecified atherosclerosis); I71.0 (Dissection of aorta [any part]); I71.1 (Thoracic aortic aneurysm, ruptured); I71.2 (Thoracic aortic aneurysm, without mention of rupture); I71.3 (Abdominal aortic aneurysm, ruptured); I71.4 (Abdominal aortic aneurysm, without mention of rupture); I71.5 (Thoracoabdominal aortic aneurysm, ruptured); I71.6 (Thoracoabdominal aortic aneurysm, without mention of rupture); I71.8 (Aortic aneurysm of unspecified site, ruptured); I71.9 (Aortic aneurysm of unspecified site, without mention of rupture); I77.8 (Other specified disorders of arteries and arterioles); J09-J18 (Influenza and pneumonia); J20.0 (Acute bronchitis due to Mycoplasma pneumoniae); J20.1 (Acute bronchitis due to Haemophilus influenzae); J20.2 (Acute bronchitis due to streptococcus); J20.3 (Acute bronchitis due to coxsackievirus); J20.4 (Acute bronchitis due to parainfluenza virus); J20.5 (Acute bronchitis due to respiratory syncytial virus); J20.6 (Acute bronchitis due to rhinovirus); J20.7 (Acute bronchitis due to echovirus); J20.8 (Acute bronchitis due to other specified organisms); J20.9 (Acute bronchitis, unspecified); J43.0 (MacLeod syndrome); J43.1 (Panlobular emphysema); J43.2 (Centrilobular emphysema); J43.8 (Other emphysema); J43.9 (Emphysema, unspecified); J44.0 (Chronic obstructive pulmonary disease with acute lower respiratory infection); J44.1 (Chronic obstructive pulmonary disease with acute exacerbation, unspecified); J44.8 (Other specified chronic obstructive pulmonary disease); J44.9 (Chronic obstructive pulmonary disease, unspecified)

** The YRBSS is conducted every other year (2017, 2019, 2021, etc.)

Copyright © 2022 · ARPrevention.org